The Second Circuit Court of Appeals has upheld a lower court's decision to grant a preliminary injunction against Colin Clarke, M.D., and his medical practice, Colin Clarke MD P.C., in a case involving alleged fraudulent claims against GEICO Indemnity Company. The court ruled on October 29, 2026, in case number 24-1611, affirming that the injunction was necessary to prevent further fraudulent activities while the case is pending.

This ruling affects healthcare providers and insurance companies, particularly in New York, where the no-fault automobile insurance laws are intended to protect insured individuals by covering medical expenses from car accidents. The decision is significant as it addresses the integrity of the no-fault insurance system and the prevention of fraud.

Background

The parties involved in this case are GEICO Indemnity Company, GEICO General Insurance Company, and GEICO Casualty Company (collectively referred to as GEICO) as the plaintiffs, and Colin Clarke, M.D., along with Colin Clarke MD P.C. as the defendants. GEICO filed a lawsuit against the defendants in 2023, alleging that they were involved in a fraudulent scheme to exploit the state's no-fault insurance laws.

The dispute centers around allegations that the Clarke Providers, under the control of unlicensed individuals, submitted fraudulent claims for medical services that were either unnecessary or not provided at all. GEICO claims that these fraudulent activities have resulted in significant financial losses and that the defendants have initiated numerous arbitration actions against GEICO to collect on these fraudulent claims.

After GEICO filed its lawsuit, the district court granted a preliminary injunction on May 23, 2024, which halted all pending arbitration actions related to these claims. The court also dismissed the counterclaims filed by the Clarke Providers. The defendants subsequently appealed both the injunction and the dismissal of their counterclaims.

The Ruling

The Second Circuit Court ruled in favor of GEICO, affirming the district court's decision to grant the preliminary injunction and dismiss the counterclaims. The court stated, "The district court did not abuse its discretion in granting GEICO’s motion for a preliminary injunction." The ruling emphasized that the injunction was crucial to prevent further fraudulent claims while the case is ongoing.

In its decision, the court highlighted that the appellants failed to demonstrate any factual disputes that warranted a hearing on the injunction. The court noted, "Appellants failed to identify for the district court any factual disputes that necessitated such a hearing." This ruling indicates that the court found sufficient evidence in GEICO's claims to justify the injunction without requiring additional hearings.

Impact

This ruling has significant implications for the healthcare and insurance industries, particularly in New York. By affirming the injunction, the court reinforced the importance of maintaining the integrity of the no-fault insurance system and protecting it from fraudulent claims. This case sets a precedent for how courts may handle similar allegations of fraud in the future, particularly in cases where healthcare providers are accused of exploiting insurance laws.

The decision also serves as a warning to other healthcare providers who may engage in similar practices, as the court's ruling emphasizes the legal consequences of such actions. It highlights the court's willingness to take strong measures to prevent fraud and protect the interests of insurance companies and their policyholders.

What's Next

The defendants may seek further legal avenues, including a possible appeal to the U.S. Supreme Court, although the court filing did not indicate any immediate plans for such action. There may also be related cases pending that could arise from the ongoing investigations into fraudulent practices in the healthcare industry.